Development of Rho-kinase inhibitors for cardiovascular medicine

H Shimokawa, M Rashid - Trends in pharmacological sciences, 2007 - cell.com
Rho-kinase (ROCK) is one of the downstream effectors of the small G-protein Rho. The Rho–
ROCK pathway has an important role in mediating various cellular functions, including …

[HTML][HTML] ROCK1 induces endothelial-to-mesenchymal transition in glomeruli to aggravate albuminuria in diabetic nephropathy

H Peng, Y Li, C Wang, J Zhang, Y Chen, W Chen… - Scientific reports, 2016 - nature.com
Endothelial-to-mesenchymal transition (EndMT) can cause loss of tight junctions, which in
glomeruli are associated with albuminuria. Here we evaluated the role of EndMT in the …

Rho kinase as a therapeutic target in cardiovascular disease

M Surma, L Wei, J Shi - Future cardiology, 2011 - Future Medicine
Rho kinase (ROCK) belongs to the AGC (PKA/PKG/PKC) family of serine/threonine kinases
and is a major downstream effector of the small GTPase RhoA. ROCK plays central roles in …

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases

M Dong, BP Yan, JK Liao, YY Lam, GWK Yip… - Drug discovery today, 2010 - Elsevier
The Rho/rho-kinase (ROCK) pathway has an important role in the pathogenesis of several
cardiovascular diseases. The activation of ROCK is involved in the regulation of vascular …

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

E Hu, D Lee - Expert Opinion on Therapeutic Targets, 2005 - Taylor & Francis
Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via
interaction with the small GTP-binding protein RhoA. Growing evidence suggests that RhoA …

Signaling pathways in diabetic nephropathy

D Kawanami, K Matoba, K Utsunomiya - 2016 - digitum.um.es
Diabetic nephropathy (DN) is a major cause of end-stage renal disease (ESRD), however,
specific treatment for DN has not yet been elucidated. Therefore, it is critically important to …

Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease

L Zhou, F Liu, XR Huang, F Liu, H Chen… - American journal of …, 2011 - karger.com
Background: Although blockade of Rho kinase with pharmacologic inhibitors ameliorates
renal fibrosis and diabetic kidney disease (DKD), the underlined mechanisms remain largely …

[HTML][HTML] Rho kinase and hypertension

A Wirth - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
Arterial hypertension is a multifactorial disease that is characterised by increased peripheral
vascular resistance often accompanied by smooth muscle cell hypertrophy and proliferation …

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

C Hahmann, T Schroeter - Cellular and Molecular Life Sciences, 2010 - Springer
The emerging critical implications of Rho/Rho-kinase (ROCK) signaling in
neurodegenerative diseases, glaucoma, renoprotection, diabetes and cancer have sparked …

[HTML][HTML] Rho kinase cascade activation in circulating leukocytes in patients with diabetes mellitus type 2

MP Ocaranza, P Valderas, J Moya, L Gabrielli… - Cardiovascular …, 2020 - Springer
Background The intracellular ROCK signaling pathway is an important modulator of blood
pressure and of cardiovascular and renal remodeling when Rho-kinase activity is increased …